Elite Pharmaceuticals Inc (ELTP)

[lasers]

Sale of Novel is NOT necessary at all. $ELTP will continue to wait on Novel as it simply keeps increasing in value.

There is only a small gap now in what $ELTP needs in monies to complete the necessary expenses to bring ELI200/201 to manufacturing/marketing. The revenues from ELI200/201 + ANDAs will support what is needed for ELI216 trial completion following into the manufacturing/marketing.

IMO $ELTP uses the new shares in another LPC, or equivalent. EPIC purchases of warrants to shares also brings more monies into $ELTP treasuries.

$ELTP remains open to reasonable partnership terms. As I said before the "old" Actavis team is the new $ELTP leadership. Discussions with the "new" Actavis is Watson and they play "hardball" Nasrat has all doors open and will maximize $ELTP shareholders value.